Journal articleNat Med · July 2026
Controlled human influenza infection studies can uniquely interrogate the early immune factors associated with clinical outcome. In this study, 27 healthy volunteers with low strain-specific serum neutralizing antibody levels were challenged with influenza ...
Full textLink to itemCite
Journal articleNat Genet · February 2026
The epigenome of human immune cells is shaped by both genetics and environmental factors, yet the relative contributions of these influences remain incompletely characterized. Here we use single-nucleus methylation sequencing and assay for transposase-acce ...
Full textLink to itemCite
Journal articleProteomics · December 3, 2025
The proteomic analysis of blood is routine for disease phenotyping and biomarker development. Blood is commonly separated into soluble and cellular fractions. However, this can introduce pre-analytical variability, and analysis of a single component (which ...
Full textLink to itemCite
Journal articleCell Rep · October 28, 2025
Viral infections can induce prolonged changes in innate immunity. Here, we use blood samples from a human influenza H3N2 challenge study (NCT03883113) to perform comprehensive multi-omics analyses. We detect remodeling of immune programs in circulating inn ...
Full textLink to itemCite
Journal articleJCI Insight · October 22, 2025
BACKGROUNDUnderstanding age-associated differences in acute and memory adaptive immunity to SARS-CoV-2 and how they contribute to more favorable outcomes in children is critically important.METHODSWe evaluated SARS-CoV-2-specific T cell, B cell, and antibo ...
Full textLink to itemCite
Journal articleAnimal Model Exp Med · October 2025
BACKGROUND: Bacterial pneumonia remains a leading cause of morbidity and mortality worldwide despite the widespread availability of antibiotics. Novel pneumonia therapies and biomarkers are urgently needed to improve outcomes and advance personalized thera ...
Full textLink to itemCite
Journal articleBMC Infect Dis · May 8, 2025
BACKGROUND: Predicting which patients will develop severe COVID-19 complications could improve clinical care. Peripheral blood cytokine profiles may predict the severity of SARS-CoV-2 infection, but none have been identified in US Veterans. METHODS: We ana ...
Full textLink to itemCite
Journal articleNat Commun · March 10, 2025
Age is among the strongest risk factors for severe outcomes from SARS-CoV-2 infection. Here we describe upper respiratory tract (URT) and peripheral blood transcriptomes of 202 participants (age range of 1 week to 83 years), including 137 non-hospitalized ...
Full textOpen AccessLink to itemCite
Journal articleOpen Forum Infect Dis · January 2025
BACKGROUND: Difficulty discriminating bacterial versus viral etiologies of infection drives unwarranted antibacterial prescriptions and, therefore, antibacterial resistance. METHODS: Utilizing a rapid portable test that measures peripheral blood host gene ...
Full textLink to itemCite
Journal articleFront Public Health · 2025
BACKGROUND: Expanding SARS-CoV-2 testing was a critical part of community-based health efforts during the COVID-19 pandemic. In the RADx-UP consortium, a large NIH-funded network of community-engaged researchers in the United States, investigators were abl ...
Full textLink to itemCite
Journal articleJ Clin Transl Sci · 2025
INTRODUCTION: Distinguishing viral versus bacterial lower respiratory tract infection (LRTI) is challenging. We previously developed a rapid, host response-based test (Biomeme HR-B/V assay) using peripheral blood samples to identify viral versus bacterial ...
Full textLink to itemCite
Journal articleClin Microbiol Rev · December 10, 2024
SUMMARYDetection of the presence of infection and its etiology must be accurate and timely to facilitate appropriate antimicrobial use. Diagnostic strategies that rely solely on pathogen detection often are insufficient due to poor test characteristics, in ...
Full textLink to itemCite
Journal articleBMJ Open Respir Res · August 3, 2024
BACKGROUND: Pneumonia due to typical bacterial, atypical bacterial and viral pathogens can be difficult to clinically differentiate. Host response-based diagnostics are emerging as a complementary diagnostic strategy to pathogen detection. METHODS: We used ...
Full textLink to itemCite
Journal articleOpen Forum Infect Dis · August 2024
BACKGROUND: Plasma microbial cell-free DNA (mcfDNA) sequencing can establish the etiology of multiple infectious syndromes by identifying microbial DNA in plasma. However, data are needed to define the clinical scenarios where this tool offers the highest ...
Full textLink to itemCite
Journal articleClin Infect Dis · March 20, 2024
BACKGROUND: Pneumonia is a common cause of morbidity and mortality, yet a causative pathogen is identified in a minority of cases. Plasma microbial cell-free DNA sequencing may improve diagnostic yield in immunocompromised patients with pneumonia. METHODS: ...
Full textLink to itemCite
Journal articleOpen Forum Infect Dis · March 2024
BACKGROUND: Index-cluster studies may help characterize the spread of communicable infections in the presymptomatic state. We describe a prospective index-cluster sampling strategy (ICSS) to detect presymptomatic respiratory viral illness and its implement ...
Full textLink to itemCite
Journal articleiScience · January 19, 2024
To elucidate host response elements that define impending decompensation during SARS-CoV-2 infection, we enrolled subjects hospitalized with COVID-19 who were matched for disease severity and comorbidities at the time of admission. We performed combined si ...
Full textOpen AccessLink to itemCite
Journal articleEpigenomics · 2024
Aim: The epigenome influences gene regulation and phenotypes in response to exposures. Epigenome assessment can determine exposure history aiding in diagnosis.Materials & methods: Here we developed and implemented a machine learning algorithm, the exposure ...
Full textLink to itemCite
Journal articleFront Immunol · 2024
INTRODUCTION: Influenza virus infections are a major global health problem. Influenza can result in mild/moderate disease or progress to more severe disease, leading to high morbidity and mortality. Severity is thought to be primarily driven by immunopatho ...
Full textLink to itemCite
Journal articleFront Immunol · 2024
INTRODUCTION: Dysregulated host cytokine responses to SARS-CoV-2 infection are a primary cause of progression to severe disease, whereas early neutralizing antibody responses are considered protective. However, there are gaps in understanding the early tem ...
Full textLink to itemCite
Journal articlePLoS One · 2024
Immune responses during acute infection often contain canonical elements which are shared across the responses to an array of agents within a given pathogen class (i.e., respiratory viral infection). Identification of these shared, canonical elements acros ...
Full textLink to itemCite
Journal articleSci Rep · December 18, 2023
Diagnostic limitations challenge management of clinically indistinguishable acute infectious illness globally. Gene expression classification models show great promise distinguishing causes of fever. We generated transcriptional data for a 294-participant ...
Full textLink to itemCite
Journal articleJ Infect Dis · August 11, 2023
BACKGROUND: We evaluated the associations between baseline influenza virus-specific hemagglutination inhibition (HAI) and microneutralization (MN) titers and subsequent symptomatic influenza virus infection in a controlled human infection study. METHODS: W ...
Full textLink to itemCite
Journal articleOpen Forum Infect Dis · July 2023
BACKGROUND: Over 870 000 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have occurred among Veterans Health Administration users, and 24 000 have resulted in death. We examined early outcomes of SARS-CoV-2 infection in hospitalized ...
Full textLink to itemCite
Journal articleCell · June 22, 2023
Systemic candidiasis is a common, high-mortality, nosocomial fungal infection. Unexpectedly, it has emerged as a complication of anti-complement C5-targeted monoclonal antibody treatment, indicating a critical niche for C5 in antifungal immunity. We identi ...
Full textLink to itemCite
Journal articleJ Infect Dis · April 12, 2023
BACKGROUND: The COVID-19 pandemic highlighted the need for early detection of viral infections in symptomatic and asymptomatic individuals to allow for timely clinical management and public health interventions. METHODS: Twenty healthy adults were challeng ...
Full textLink to itemCite
Journal articleLancet Infect Dis · April 2023
BACKGROUND: Lower respiratory tract infections are frequently treated with antibiotics, despite a viral cause in many cases. It remains unknown whether low procalcitonin concentrations can identify patients with lower respiratory tract infection who are un ...
Full textOpen AccessLink to itemCite
Journal articleCell Rep Methods · February 27, 2023
Assays detecting blood transcriptome changes are studied for infectious disease diagnosis. Blood-based RNA alternative splicing (AS) events, which have not been well characterized in pathogen infection, have potential normalization and assay platform stabi ...
Full textOpen AccessLink to itemCite
Journal articlePLoS One · 2023
Renal transplantation from hepatitis C (HCV) nucleic acid amplification test-positive (NAAT-positive) donors to uninfected recipients has greatly increased the organ donation pool. However, there is concern for adverse outcomes in these recipients due to d ...
Full textLink to itemCite
Journal articleCell Syst · December 21, 2022
The identification of a COVID-19 host response signature in blood can increase the understanding of SARS-CoV-2 pathogenesis and improve diagnostic tools. Applying a multi-objective optimization framework to both massive public and new multi-omics data, we ...
Full textLink to itemCite
Journal articleCrit Care Med · December 1, 2022
OBJECTIVES: Sepsis causes significant mortality. However, most patients who die of sepsis do not present with severe infection, hampering efforts to deliver early, aggressive therapy. It is also known that the host gene expression response to infection pre ...
Full textLink to itemCite
Journal articleCell Genom · November 9, 2022
During pandemics, individuals exhibit differences in risk and clinical outcomes. Here, we developed single-cell high-throughput human in vitro susceptibility testing (scHi-HOST), a method for rapidly identifying genetic variants that confer resistance and ...
Full textLink to itemCite
Journal articleSci Rep · July 9, 2022
SARS-CoV-2 infection triggers profound and variable immune responses in human hosts. Chromatin remodeling has been observed in individuals severely ill or convalescing with COVID-19, but chromatin remodeling early in disease prior to anti-spike protein IgG ...
Full textOpen AccessLink to itemCite
Journal articleHealth Sci Rep · July 2022
PURPOSE: Several cases of symptomatic reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after full recovery from a prior episode have been reported. As reinfection has become an increasingly common phenomenon, an improved unders ...
Full textOpen AccessLink to itemCite
Journal articleJ Fungi (Basel) · April 22, 2022
Many aspects of the host response to invasive cryptococcal infections remain poorly understood. In order to explore the pathobiology of infection with common clinical strains, we infected BALB/cJ mice with Cryptococcus neoformans, Cryptococcus gattii, or s ...
Full textLink to itemCite
Journal articleJAMA Netw Open · April 1, 2022
IMPORTANCE: Bacterial and viral causes of acute respiratory illness (ARI) are difficult to clinically distinguish, resulting in the inappropriate use of antibacterial therapy. The use of a host gene expression-based test that is able to discriminate bacter ...
Full textOpen AccessLink to itemCite
Journal articleGenome Med · February 21, 2022
BACKGROUND: Measuring host gene expression is a promising diagnostic strategy to discriminate bacterial and viral infections. Multiple signatures of varying size, complexity, and target populations have been described. However, there is little information ...
Full textOpen AccessLink to itemCite
Journal articleOpen Forum Infect Dis · December 2021
BACKGROUND: Difficulty discriminating bacterial from viral infections drives antibacterial misuse. Host gene expression tests discriminate bacterial and viral etiologies, but their clinical utility has not been evaluated. METHODS: Host gene expression and ...
Full textOpen AccessLink to itemCite
Journal articleCrit Care Med · October 1, 2021
OBJECTIVES: Host gene expression signatures discriminate bacterial and viral infection but have not been translated to a clinical test platform. This study enrolled an independent cohort of patients to describe and validate a first-in-class host response b ...
Full textOpen AccessLink to itemCite
Journal articleJCI Insight · September 8, 2021
As SARS-CoV-2 continues to spread globally, questions have emerged regarding the strength and durability of immune responses in specific populations. In this study, we evaluated humoral immune responses in 69 children and adolescents with asymptomatic or m ...
Full textLink to itemCite
Journal articleJAMA Netw Open · September 1, 2021
IMPORTANCE: Currently, there are no presymptomatic screening methods to identify individuals infected with a respiratory virus to prevent disease spread and to predict their trajectory for resource allocation. OBJECTIVE: To evaluate the feasibility of usin ...
Full textOpen AccessLink to itemCite
Journal articleClin Infect Dis · August 16, 2021
BACKGROUND: Host gene expression has emerged as a complementary strategy to pathogen detection tests for the discrimination of bacterial and viral infection. The impact of immunocompromise on host-response tests remains unknown. We evaluated a host-respons ...
Full textOpen AccessLink to itemCite
Journal articleGenome Med · July 5, 2021
BACKGROUND: Candidemia is one of the most common nosocomial bloodstream infections in the United States, causing significant morbidity and mortality in hospitalized patients, but the breadth of the host response to Candida infections in human patients rema ...
Full textOpen AccessLink to itemCite
Journal articleMed · June 11, 2021
BACKGROUND: Sexual dimorphisms in immune responses contribute to coronavirus disease 2019 (COVID-19) outcomes, but the mechanisms governing this disparity remain incompletely understood. METHODS: We carried out sex-balanced sampling of peripheral blood mon ...
Full textOpen AccessLink to itemCite
Journal articleGenome Med · May 17, 2021
BACKGROUND: While genome-wide associations studies (GWAS) have successfully elucidated the genetic architecture of complex human traits and diseases, understanding mechanisms that lead from genetic variation to pathophysiology remains an important challeng ...
Full textOpen AccessLink to itemCite
Journal articleLancet Infect Dis · March 2021
BACKGROUND: Early and accurate identification of individuals with viral infections is crucial for clinical management and public health interventions. We aimed to assess the ability of transcriptomic biomarkers to identify naturally acquired respiratory vi ...
Full textOpen AccessLink to itemCite
Journal articleNat Commun · February 17, 2021
SARS-CoV-2 infection has been shown to trigger a wide spectrum of immune responses and clinical manifestations in human hosts. Here, we sought to elucidate novel aspects of the host response to SARS-CoV-2 infection through RNA sequencing of peripheral bloo ...
Full textOpen AccessLink to itemCite
Journal articleFront Immunol · 2021
Viruses cause a wide spectrum of clinical disease, the majority being acute respiratory infections (ARI). In most cases, ARI symptoms are similar for different viruses although severity can be variable. The objective of this study was to understand the sha ...
Full textOpen AccessLink to itemCite
Journal articlePLoS One · 2021
OBJECTIVES: Compare three host response strategies to distinguish bacterial and viral etiologies of acute respiratory illness (ARI). METHODS: In this observational cohort study, procalcitonin, a 3-protein panel (CRP, IP-10, TRAIL), and a host gene expressi ...
Full textOpen AccessLink to itemCite
Journal articleOpen Forum Infect Dis · June 2020
BACKGROUND: Pathogen-based diagnostics for acute respiratory infection (ARI) have limited ability to detect etiology of illness. We previously showed that peripheral blood-based host gene expression classifiers accurately identify bacterial and viral ARI i ...
Full textOpen AccessLink to itemCite
Journal articleTransl Res · May 2020
Invasive aspergillosis (IA) is a major cause of critical illness in immunocompromised (IC) patients. However, current fungal tests are limited. Disease-specific gene expression patterns in circulating host cells show promise as novel diagnostics, however i ...
Full textLink to itemCite
Journal articleJ Gerontol A Biol Sci Med Sci · March 9, 2020
BACKGROUND: Approaches for quantifying physical resilience in older adults have not been described. METHODS: We apply two conceptual approaches to defining physical resilience to existing longitudinal data sets in which outcomes are measured after an acute ...
Full textLink to itemCite
Journal articleJ Autoimmun · January 2020
Multiple sclerosis (MS) is an autoimmune demyelinating disease with progressive neurodegeneration and complex etiology likely involving genetic and environmental factors. MS has been associated with Epstein Barr virus (EBV) infection, with patients often s ...
Full textLink to itemCite
Journal articleEBioMedicine · October 2019
BACKGROUND: Distinguishing bacterial and viral respiratory infections is challenging. Novel diagnostics based on differential host gene expression patterns are promising but have not been translated to a clinical platform nor extensively tested. Here, we v ...
Full textOpen AccessLink to itemCite
Journal articleInfection · August 2019
PURPOSE: A number of scoring tools have been developed to predict illness severity and patient outcome for proven pneumonia, however, less is known about the utility of clinical prediction scores for all-cause acute respiratory infection (ARI), especially ...
Full textLink to itemCite
Journal articleVaccine · July 9, 2019
BACKGROUND: West Nile virus (WNV) is the most common mosquito-borne infection in the United States. HydroVax-001 WNV is a hydrogen peroxide inactivated, whole virion (WNV-Kunjin strain) vaccine adjuvanted with aluminum hydroxide. METHODS: We performed a ph ...
Full textLink to itemCite
Journal articleOpen Forum Infect Dis · April 2019
BACKGROUND: Excessive neutrophil migration has been correlated with influenza symptom severity. Danirixin (GSK1325756), a selective and reversible antagonist of C-X-C chemokine receptor 2, decreases neutrophil activation and transmigration to areas of infl ...
Full textLink to itemCite
Journal articlePLoS One · 2019
RATIONALE: Asthma exacerbations often occur due to infectious triggers, but determining whether infection is present and whether it is bacterial or viral remains clinically challenging. A diagnostic strategy that clarifies these uncertainties could enable ...
Full textOpen AccessLink to itemCite
Journal articleNat Commun · October 24, 2018
The response to respiratory viruses varies substantially between individuals, and there are currently no known molecular predictors from the early stages of infection. Here we conduct a community-based analysis to determine whether pre- or early post-expos ...
Full textOpen AccessLink to itemCite
Journal articleFront Microbiol · 2018
Background: Acute respiratory infections (ARIs) are the leading indication for antibacterial prescriptions despite a viral etiology in the majority of cases. The lack of available diagnostics to discriminate viral and bacterial etiologies contributes to th ...
Full textOpen AccessLink to itemCite
Journal articleJ Transl Med · June 8, 2017
BACKGROUND: Influenza challenge trials are important for vaccine efficacy testing. Currently, disease severity is determined by self-reported scores to a list of symptoms which can be highly subjective. A more objective measure would allow for improved dat ...
Full textLink to itemCite
Journal articleEBioMedicine · March 2017
Infection of respiratory mucosa with viral pathogens triggers complex immunologic events in the affected host. We sought to characterize this response through proteomic analysis of nasopharyngeal lavage in human subjects experimentally challenged with infl ...
Full textOpen AccessLink to itemCite
Journal articleJ Clin Microbiol · February 2017
Emerging pandemic infectious threats, inappropriate antibacterial use contributing to multidrug resistance, and increased morbidity and mortality from diagnostic delays all contribute to a need for improved diagnostics in the field of infectious diseases. ...
Full textLink to itemCite
Journal articlePLoS Pathog · February 2017
We characterise the evolutionary dynamics of influenza infection described by viral sequence data collected from two challenge studies conducted in human hosts. Viral sequence data were collected at regular intervals from infected hosts. Changes in the seq ...
Full textLink to itemCite
Journal articleJ Virol · December 15, 2016
UNLABELLED: Knowledge of influenza virus evolution at the point of transmission and at the intrahost level remains limited, particularly for human hosts. Here, we analyze a unique viral data set of next-generation sequencing (NGS) samples generated from a ...
Full textLink to itemCite
Journal articleJ Infect Dis · May 1, 2016
BACKGROUND: Enterotoxigenic Escherichia coli (ETEC) is a globally prevalent cause of diarrhea. Though usually self-limited, it can be severe and debilitating. Little is known about the host transcriptional response to infection. We report the first gene ex ...
Full textOpen AccessLink to itemCite
Journal articleClin Exp Immunol · March 2016
Exposure to influenza virus triggers a complex cascade of events in the human host. In order to understand more clearly the evolution of this intricate response over time, human volunteers were inoculated with influenza A/Wisconsin/67/2005 (H3N2), and then ...
Full textLink to itemCite
Journal articleAnn Am Thorac Soc · March 2016
RATIONALE: Limitations in methods for the rapid diagnosis of hospital-acquired infections often delay initiation of effective antimicrobial therapy. New diagnostic approaches offer potential clinical and cost-related improvements in the management of these ...
Full textOpen AccessLink to itemCite
Journal articleClin Trials · February 2016
The outbreak of Ebola virus disease in West Africa is the largest ever recorded. Numerous treatment alternatives for Ebola have been considered, including widely available repurposed drugs, but initiation of enrollment into clinical trials has been limited ...
Full textLink to itemCite
Journal articleSci Transl Med · January 20, 2016
Acute respiratory infections caused by bacterial or viral pathogens are among the most common reasons for seeking medical care. Despite improvements in pathogen-based diagnostics, most patients receive inappropriate antibiotics. Host response biomarkers of ...
Full textOpen AccessLink to itemCite
Journal articleOpen Forum Infect Dis · January 2016
Early, presymptomatic intervention with oseltamivir (corresponding to the onset of a published host-based genomic signature of influenza infection) resulted in decreased overall influenza symptoms (aggregate symptom scores of 23.5 vs 46.3), more rapid reso ...
Full textOpen AccessLink to itemCite
Journal articleExpert Rev Mol Diagn · 2015
A century of advances in infectious disease diagnosis and treatment changed the face of medicine. However, challenges continue to develop including multi-drug resistance, globalization that increases pandemic risks and high mortality from severe infections ...
Full textLink to itemCite
Journal articleGenome Med · 2014
BACKGROUND: Sepsis, a leading cause of morbidity and mortality, is not a homogeneous disease but rather a syndrome encompassing many heterogeneous pathophysiologies. Patient factors including genetics predispose to poor outcomes, though current clinical ch ...
Full textOpen AccessLink to itemCite
Journal articleJ Clin Virol · December 2013
BACKGROUND: Leukocyte counts and differentials are commonly acquired in patients with suspected respiratory viral infections and may contribute diagnostic information. However, most published work is limited to a single timepoint at initial presentation to ...
Full textLink to itemCite
Journal articleSci Transl Med · September 18, 2013
Improved ways to diagnose acute respiratory viral infections could decrease inappropriate antibacterial use and serve as a vital triage mechanism in the event of a potential viral pandemic. Measurement of the host response to infection is an alternative to ...
Full textLink to itemCite
Journal articleAntivir Ther · 2013
BACKGROUND: Antivirals reduce influenza viral replication and illness measures, particularly if initiated early, within 48 h of symptom onset. Whether experimental antivirals that reduce respiratory syncytial virus (RSV) load would also reduce disease is u ...
Full textLink to itemCite
Journal articlePLoS One · 2013
There is great potential for host-based gene expression analysis to impact the early diagnosis of infectious diseases. In particular, the influenza pandemic of 2009 highlighted the challenges and limitations of traditional pathogen-based testing for suspec ...
Full textOpen AccessLink to itemCite
Journal articlePLoS Genet · August 2011
Exposure to influenza viruses is necessary, but not sufficient, for healthy human hosts to develop symptomatic illness. The host response is an important determinant of disease progression. In order to delineate host molecular responses that differentiate ...
Full textOpen AccessLink to itemCite
Journal articlePLoS One · 2011
BACKGROUND: During the recent H1N1 influenza pandemic, excess morbidity and mortality was seen in young but not older adults suggesting that prior infection with influenza strains may have protected older subjects. In contrast, a history of recent seasonal ...
Full textOpen AccessLink to itemCite
Journal articleJ Mol Med (Berl) · July 2010
Autoantibodies to ribosomal P (ribo P) are found in 15-30% of systemic lupus erythematosus (SLE) patients and are highly specific for SLE. The goal of this study is to assess the temporal association of anti-ribosomal P (anti-P) responses with SLE disease ...
Full textLink to itemCite
Journal articlePLoS One · March 10, 2010
Systemic lupus erythematosus (SLE) is a clinically heterogeneous, humoral autoimmune disorder. The unifying feature among SLE patients is the production of large quantities of autoantibodies. Serum samples from 129 patients collected before the onset of SL ...
Full textLink to itemCite
Journal articleArthritis Rheum · July 2007
OBJECTIVE: Specific events that occur during the development of systemic lupus erythematosus (SLE) can be quite variable among individual patients. The aim of this study was to identify patterns that distinguish early clinical events in SLE and to assess w ...
Full textLink to itemCite
Journal articleLupus · 2007
Systemic lupus erythematosus (SLE) is a clinically diverse, complex autoimmune disease which may present with coincident onset of many criteria or slow, gradual symptom accrual. Early intervention has been postulated to delay or prevent the development of ...
Full textLink to itemCite
Journal articleArthritis Rheum · January 2006
OBJECTIVE: New examples support the concept that host immune responses to pathogenic organisms can act as the nidus for autoimmunity. Two such examples implicate the Epstein-Barr virus (EBV) in systemic lupus erythematosus (SLE), i.e., data consistent with ...
Full textLink to itemCite
Journal articleFree Radic Biol Med · March 15, 2005
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with autoantibodies as a near universal feature of the disease. The Ro ribonucleoprotein particle, composed of a 60-kDa protein noncovalently associated with human cytoplasmic RNA, is the t ...
Full textLink to itemCite
Journal articleNat Med · January 2005
The origins of autoimmunity in systemic lupus erythematosus (SLE) are thought to involve both genetic and environmental factors. To identify environmental agents that could potentially incite autoimmunity, we have traced the autoantibody response in human ...
Full textLink to itemCite
Journal articleArthritis Rheum · April 2004
OBJECTIVE: To determine whether antiphospholipid antibodies (aPL) occur before the diagnosis of systemic lupus erythematosus (SLE) and before initial clotting events, and whether their presence early in the disease course influences clinical outcome. METHO ...
Full textLink to itemCite
Journal articleProc Natl Acad Sci U S A · March 9, 2004
A subset of lupus patients with severe nephritis and anti-nRNP reactivity produces autoantibodies primarily against two major epitopes of the nRNP A (also known as U1A) protein. These sequences span amino acids 44-56 (A3) and amino acids 103-115 (A6). Thes ...
Full textLink to itemCite
Journal articleN Engl J Med · October 16, 2003
BACKGROUND: Although much is known about the natural history of systemic lupus erythematosus (SLE), the development of SLE autoantibodies before the diagnosis of the disease has not been extensively explored. We investigated the onset and progression of au ...
Full textLink to itemCite
Journal articleJ Med Virol · June 2003
The spectrum of antibodies against Epstein-Barr virus nuclear antigen-1 (EBNA-1) in patients with a recent history of infectious mononucleosis and nonaffected EBV-positive individuals has been characterized by epitope mapping. Sera were evaluated for antib ...
Full textLink to itemCite
Journal articleLupus · 2003
The initial clinical course of systemic lupus erythematosus (SLE) is variable, ranging from relatively minor manifestations progressing over years to rapid onset of fulminate disease. We sought to identify factors associated with the rapid manifestation of ...
Full textLink to itemCite
Journal articleScand J Immunol · October 2002
Recent data have suggested that autoantibodies in lupus can progress from simple immunity against a few antigenic structures to a complex response against multiple autoantigens. Our aim was to determine whether these diverse epitope patterns can indeed be ...
Full textLink to itemCite
Journal articleJ Immunol · February 15, 2002
Autoantibodies directed against spliceosomal proteins are a common and specific feature of systemic lupus erythematosus. These autoantibodies target a collection of proteins, including Sm B, B', D1, D2, and D3. We define the common antigenic targets of Sm ...
Full textLink to itemCite
Journal articleJ Mol Recognit · 2002
The U1A (or nRNP A) protein is known to play a critical role in eukaryotic pre-mRNA splicing and polyadenylation. Previous studies revealed that several mouse monoclonal antibodies (MAbs) recognized U1A as part of the U1snRNP, while MAb 12E12 was unique in ...
Full textLink to itemCite
Journal articleFront Biosci · October 1, 2001
Systemic lupus erythematosus (SLE) is a devastating autoimmune disease with no known cure. Lupus patients suffer from a myriad of clinical symptoms which variably include arthritis, pleuritis, pericarditis, vasculitis, and nephritis. The underlying mechani ...
Full textLink to itemCite
Journal articleBiochem Biophys Res Commun · August 3, 2001
An unusual feature of the gene for the spliceosomal protein SmB/B' is the presence of an unusually long alternative open reading frame (aORF) which could encode 220 amino acids. We cloned and expressed this aORF protein and used immunological assays to det ...
Full textLink to itemCite
Journal articleJ Autoimmun · February 1999
Autoantibodies binding the Sm B and B' peptides (B/B') are commonly associated with systemic lupus erythematosus in man and in MRL lpr/lpr mice. The linear antigenic regions of two anti-Sm B/B' murine monoclonal auto-antibodies have been mapped using overl ...
Full textLink to itemCite
Journal articleFASEB Journal · March 20, 1998
The peptides Sm B and B' are components of the spliceosome which are commonly bound by autoantibodies in systemic lupus erythematosus in man and in MRL lpr/lpr mice. We have characterized anti-Sm B/B' murine monoclonal autoantibodies. Sequence analysis of ...
Cite
Journal articleFASEB Journal · 1998
Systemic lupus erythematosus is an autoimmune disorder characterized by the production of antibodies to ribonucleoproteins, including 60kD Ro (SS-A), La (SS-B), and 52kD Ro. Spliceosomal proteins, such as Sm and nRNP are also common targets of lupus autoim ...
Cite
Journal articleFASEB Journal · 1998
Systemic lupus erythematosus is an autoimmune disorder characterized by the production of large amounts of autoantibodies. Over 40% of lupus patient sera contain anti-RNP antibodies. Two binding patterns to nRNP in patients have been found, one complex wit ...
Cite